| 3CLpro | 3-Chymotrypsin-like protease |
| ACE2 | Angiotensin converting enzyme 2 |
| ADALP1 | Adenosine deaminase like protein 1 |
| CES1 | Carboxylesterase 1 |
| COVID-19 | Coronavirus infectious disease of 2019 |
| CRM1 | Chromosome region maintenance 1 |
| ERGIC | Endoplasmic reticulum–Golgi intermediate compartment |
| GTP | Guanosine triphosphate |
| GUK1 | Guanylate kinase 1 |
| HINT1 | Histidine triad nucleotide-binding protein 1 |
| HBV | Hepatitis B virus |
| HCV | Hepatitis C virus |
| HIV | Human immunodeficiency virus |
| INF | Interferon |
| IL | Interleukin |
| MERS-CoV | Middle East respiratory syndrome coronavirus |
| Mpro | Main protease |
| NDPK | Nucleoside diphosphate kinase |
| NSAIDs | Nonsteroidal anti-inflammatory drugs |
| NSP | Nonstructural protein |
| NF-AT | Nuclear factor of activated T-cells |
| mTOR | Mammalian target of rapamycin |
| PLpro | Papain-like protease |
| RdRp | RNA-dependent RNA polymerase |
| SARS-CoV | Severe acute respiratory syndrome coronavirus |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus-2 |
| TRMPSS2 | Transmembrane protease serine 2 |